These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 10566121

  • 21. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W, Majkowska L, Stefański A, Moleda P.
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [Abstract] [Full Text] [Related]

  • 22. Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women.
    Moeller LE, Peterson CT, Hanson KB, Dent SB, Lewis DS, King DS, Alekel DL.
    Menopause; 2003; 10(4):322-31. PubMed ID: 12851515
    [Abstract] [Full Text] [Related]

  • 23. Effect of dairy supplementation on body composition and insulin resistance in mice.
    Johnson MS, Jumbo-Lucioni P, Watts AJ, Allison DB, Nagy TR.
    Nutrition; 2007; 23(11-12):836-43. PubMed ID: 17826954
    [Abstract] [Full Text] [Related]

  • 24. Body composition assessment in type 1 diabetes mellitus patients over 15 years old.
    Gómez JM, Maravall FJ, Soler J, Fernández-Castañer M.
    Horm Metab Res; 2001 Nov; 33(11):670-3. PubMed ID: 11733870
    [Abstract] [Full Text] [Related]

  • 25. [Body composition in type 1 diabetes mellitus. Bio-impedance measurements in 274 diabetic children, adolescents and young adults].
    Bartz J, Sulzbach U, Heinze E, Teller WM, Holl RW.
    Dtsch Med Wochenschr; 1997 Jun 20; 122(25-26):815-9. PubMed ID: 9244669
    [Abstract] [Full Text] [Related]

  • 26. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A, Lüddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L, PREDICTIVE Study Group.
    Int J Clin Pract; 2008 Apr 20; 62(4):659-65. PubMed ID: 18324957
    [Abstract] [Full Text] [Related]

  • 27. [How to minimize weight gain associated with insulin treatment].
    Philippe J.
    Rev Med Suisse; 2010 Jun 09; 6(252):1199-200, 1202-4. PubMed ID: 20614755
    [Abstract] [Full Text] [Related]

  • 28. Serial body composition by bioimpedance analysis in a diabetic subject with rapid insulin-induced weight gain--a case report.
    Lee IT, Lin SY, Sheu WH.
    Kaohsiung J Med Sci; 2002 Jan 09; 18(1):45-8. PubMed ID: 12017983
    [Abstract] [Full Text] [Related]

  • 29. Potential causes of weight gain in type 1 diabetes mellitus.
    Jacob AN, Salinas K, Adams-Huet B, Raskin P.
    Diabetes Obes Metab; 2006 Jul 09; 8(4):404-11. PubMed ID: 16776747
    [Abstract] [Full Text] [Related]

  • 30. Effect of added insulin on body composition of gastroenterologic patients receiving intravenous nutrition--a controlled clinical trial.
    MacFie J, Yule AG, Hill GL.
    Gastroenterology; 1981 Aug 09; 81(2):285-9. PubMed ID: 6786952
    [Abstract] [Full Text] [Related]

  • 31. 'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients.
    Sallé A, Ryan M, Guilloteau G, Bouhanick B, Berrut G, Ritz P.
    Br J Nutr; 2005 Dec 09; 94(6):931-7. PubMed ID: 16351770
    [Abstract] [Full Text] [Related]

  • 32. The gain game.
    Gebel E.
    Diabetes Forecast; 2012 Oct 09; 65(10):28-9. PubMed ID: 23038947
    [No Abstract] [Full Text] [Related]

  • 33. Pronounced weight gain in insulin-treated patients with type 2 diabetes mellitus is associated with an unfavourable cardiometabolic risk profile.
    Jansen HJ, Vervoort G, van der Graaf M, Tack CJ.
    Neth J Med; 2010 Nov 09; 68(11):359-66. PubMed ID: 21116029
    [Abstract] [Full Text] [Related]

  • 34. Determinants of excessive weight gain after the initiation of insulin therapy in type 2 diabetes mellitus: Retrospective inception cohort study (ZODIAC 60).
    Edens MA, van Dijk PR, Hak E, Bilo HJG.
    Diabetes Res Clin Pract; 2023 Jun 09; 200():110719. PubMed ID: 37196706
    [Abstract] [Full Text] [Related]

  • 35. Comment on Balkau et al. Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care 2014;37:2108-2113.
    Finer N.
    Diabetes Care; 2014 Dec 09; 37(12):e265. PubMed ID: 25414400
    [No Abstract] [Full Text] [Related]

  • 36. Response to comment on Balkau et al. Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care 2014;37:2108-2113.
    Balkau B, Home PD, Vincent M, Marre M, Freemantle N.
    Diabetes Care; 2014 Dec 09; 37(12):e266. PubMed ID: 25414401
    [No Abstract] [Full Text] [Related]

  • 37. Weight Management for Patients with Type 2 Diabetes: Impact of Newer Antidiabetic Therapies on Body Weight.
    Campos C.
    J Fam Pract; 2018 Aug 09; 67(8 suppl):S61-S66. PubMed ID: 30137056
    [No Abstract] [Full Text] [Related]

  • 38. Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis.
    Klaver M, Dekker MJHJ, de Mutsert R, Twisk JWR, den Heijer M.
    Andrologia; 2017 Jun 09; 49(5):. PubMed ID: 27572683
    [Abstract] [Full Text] [Related]

  • 39. Antidiabetic medications and weight gain: implications for the practicing physician.
    McFarlane SI.
    Curr Diab Rep; 2009 Jun 09; 9(3):249-54. PubMed ID: 19490828
    [Abstract] [Full Text] [Related]

  • 40. Does hormone therapy keep you lean or fat?
    Ravnikar VA.
    Menopause; 2011 Jan 09; 18(1):13-4. PubMed ID: 21107295
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.